cannabis withdrawal phenotype
Evidence from:
primary |
all sources
Related entities (77)
Mentioned in (8)
Papers in which this entity is mentioned.
- Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
- A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
- A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. (2013)
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
- The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
- Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
- Pharmacological treatment of cannabis dependence. (2011)
- Cannabis withdrawal in the United States: results from NESARC. (2008)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| cannabis withdrawal | phenotype | 7 | 51 |
| cannabis withdrawal syndrome | phenotype | 5 | 11 |
| cannabis withdrawal symptoms | phenotype | 4 | 11 |
| cws | phenotype | — | — |
| withdrawal from cannabis | phenotype | — | — |
| withdrawal symptoms of cannabis | phenotype | — | — |